Johnson & Johnson and GlaxoSmithKline have contributed to a series B round for Pulmocide, a respiratory therapy spinout of Imperial College London.

Touchstone Innovations, which previously led a series A in 2013, has put $3.7m into the series B round and participated alongside several corporates such as GlaxoSmithKline.

Touchstone Innovations, which co-founded the cellular immunotherapy developer in 2007, has contributed to another funding round.

Asia Pacific Internet Group led the domestic services platform's latest round, in which it raised $10.8m, reportedly at a lower valuation than its $47m series B.

Rakuten and existing investor Allianz have contributed to a round of undisclosed size that lifted the e-commerce insurance company's total funding to more than $32m.

Nottingham spinout Monica Healthcare, which has developed monitoring technology for expectant mothers and their babies, has been acquired by GE Healthcare.

Oxford University has partnered Kingsley Capital Partners to conduct research into cannabis-based medication through a new company dubbed Oxford Cannabinoid Technologies.

The construction materials producer has formed an open innovation and venture investment unit and will launch a startup competition later this month.